Company Profile

Company Overview

GTx, Inc., headquartered in Memphis, Tennessee, is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle wasting and other serious medical conditions. GTx's lead drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens.